“Evaluation of pharmacokinetic and pharmacodynamic interaction between repaglinide and atazanavir in healthy, diabetic and hepatic impaired rats: possible inhibition of CYP3A, OATP, and P-glycoprotein transporters”, ADMET DMPK, vol. 4, no. 3, pp. 269–279, Oct. 2016, doi: 10.5599/admet.4.3.328.